Technology developed by Zahoransky significantly accelerates housing production and reduces cost for insulin pens and auto-injectors.
Legislation sponsored by Senator Michael Testa (R-1) to expand access to epinephrine in schools, colleges, and youth camps ...
It was illegal for educators to buy adrenaline auto-injectors for general use, and trained staff could only use ones on ...
Q2 2026 Earnings Call November 12, 2025 4:00 AM ESTCompany ParticipantsSam GhezelbashSimon Michel - CEO & Member of ...
These are the precautions parents of children allergic to certain foods can take to ensure their young one's safety.
Offers no-hassle, free virtual visit with healthcare provider for patients to receive neffy for $0 co-pay if eligible with commercial insurance ...
And this is if I can complement the we see that the trajectory is robust our big international clients, in particular the bio ...
Federal judge rules divestiture plan addresses competition concerns in GTCR's acquisition of Surmodics despite FTC claims of ...
"We are executing our commercial strategy across multiple fronts, with each element reinforcing the others to drive momentum,” said Richard Lowenthal, Co-Founder, President and CEO of ARS Pharma. "Our ...
The global disposable medical device market is set to expand from USD 113.95 billion in 2025 to USD 144.85 billion by 2030, driven by a 4.9% CAGR. Factors such as heightened concern over ...
Alembic Pharmaceuticals Limited has announced that it has received final approval from the US Food & Drug Administration ...
Detailed price information for Ars Pharmaceuticals Inc (SPRY-Q) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results